Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

The fate of benzotriazole pollutants in an urban oxic intergranular aquifer.

Water Research 2018 March 16
Benzotriazoles (BTs) are considered as Contaminants of Emerging Concern (CECs); however, information about their fate in aquifers continues to be absent. This was the focus of the present study, which provides the first evidence for relevant BTs' degradation products (BTTPs) in urban aquifers that may impact the groundwater quality. The mechanisms and biotransformation pathways of BTs were investigated in an oxic intergranular medium. The BTs and BTTPs were identified and quantified by gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) analytical techniques based on reference standards and internal materials. The major transformation products were identified as 2-methyl-2H-benzotriazole (2-MeBT) for the degradation of 1H-benzotriazole (BT) and as 2,4-dimethyl-2H-benzotriazole (2,4-dMeBT) and 1,4-dimethyl-1H-benzotriazole (1,4-dMeBT) for the degradation of 4-methyl-1H-benzotriazole (4-MeBT), and most probably also 5-methyl-1H-benzotriazole (5-MeBT). The leakage of wastewater pipelines is most probably the source of BTs. Sediments with a lower hydraulic conductivity give rise to perched aquifer conditions that lead to the temporal storage of leaking effluents and presumably the majority of BTs' transformation processes via methylation and tautomerization. The most stable BTTPs entered the saturated zone of the aquifer, where they prevailed. Concentrations up to 1500 ng L-1 were measured for the 2,4-dMeBT, which suggest a contamination risk for groundwater that is or may be used as a source for drinking water in the case of a constant input of pollutant loads from sewer systems.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app